Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Provention Bio Inc
(NQ:
PRVB
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Apr 26, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Provention Bio Inc
< Previous
1
2
3
4
5
6
7
8
Next >
12 Health Care Stocks Moving In Monday's Pre-Market Session
November 22, 2021
Gainers iSpecimen (NASDAQ:ISPC) stock rose 31.09% to $6.45 during Monday's pre-market session. The company's market cap stands at $44.9 million. Provention Bio (...
Via
Benzinga
Provention Bio, inc (PRVB) Q3 2021 Earnings Call Transcript
November 06, 2021
PRVB earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
November 04, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &...
Via
Benzinga
Exposures
COVID-19
The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO
August 05, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (...
Via
Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...
Via
Benzinga
Provention Bio Reveals Early Data For Coxsackievirus B Vaccine Candidate
October 26, 2021
Provention Bio Inc (NASDAQ: PRVB) has announced interim results from the PROVENT Phase 1 trial of PRV-101. PRV-101 is a polyvalent inactivated coxsackievirus B (...
Via
Benzinga
Precigen Posts Additional Interim Data From Type 1 Diabetes Trial
October 01, 2021
Precigen Inc's (NASDAQ: PGEN) subsidiary Precigen ActoBio has announced additional interim data from Phase 1b/2a study of AG019 ActoBiotics for...
Via
Benzinga
Provention Bio, Inc. (NASDAQ:PRVB) Long Term Investor Notice: Investigation over Possible Wrongdoing
September 22, 2021
San Diego, CA -- (SBWIRE) -- 09/22/2021 -- An investigation was announced over possible breaches of fiduciary duties by certain directors of Provention Bio, Inc.
Via
SBWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Provention Bio, inc (PRVB) Q2 2021 Earnings Call Transcript
August 06, 2021
PRVB earnings call for the period ending June 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Attention Biotech Investors: Mark Your Calendar For August PDUFA Dates
August 02, 2021
The month of July was disappointing from the perspective of Food and Drug Administration decisions, as the agency handed down mostly negative verdi...
Via
Benzinga
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
August 01, 2021
Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results....
Via
Benzinga
Exposures
Product Safety
PRVB Final Deadline: Bronstein, Gewirtz & Grossman, LLC Reminds Provention Bio, Inc. Investors of Class Action and Lead Plaintiff Deadline: July 20, 2021
July 19, 2021
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Provention Bio, Inc. (PRVB)
July 16, 2021
From
The Law Offices of Frank R. Cruz
Via
Business Wire
Is Provention Bio a Bad News Buy?
July 16, 2021
There's a good case this biotech stock is now at least somewhat undervalued.
Via
The Motley Fool
Exposures
Product Safety
The Week Ahead In Biotech: Adcom Test Awaits FibroGen, Data Readouts, IPOs In The Mix
July 11, 2021
Biopharma stocks closed the holiday-shortened week lower amid a lack of any significant news flow. On the drug approval front, Provention Bio, Inc. (NASDAQ: PRVB) faced a setback...
Via
Benzinga
NASDAQ:PRVB Investor Notice: Deadline on July 20, 2021 in Lawsuit Against Provention Bio, Inc.
July 08, 2021
San Diego, CA -- (SBWIRE) -- 07/08/2021 -- The Shareholders Foundation announced that a deadline is coming up on July 20, 2021 in the lawsuit filed for certain investors of Provention Bio, Inc....
Via
SBWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
Mid-Afternoon Market Update: Dow Tumbles 300 Points; Advaxis Shares Spike Higher
July 06, 2021
Toward the end of trading Tuesday, the Dow traded down 0.86% to 34,488.53 while the NASDAQ fell 0.08% to 14,626.98. The S&P also fell, dropping 0.48% to 4,331.47. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Here's Why Provention Bio Stock Is Diving Today
July 06, 2021
The company's latest letter from the FDA wasn't what investors had hoped for.
Via
The Motley Fool
Exposures
Product Safety
The Daily Biotech Pulse: Priority Review For Amgen's Asthma Treatment, Evaxion Reports Positive Skin Cancer Readout, Quidel Recalls Lyra COVID-19 Test
July 08, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 7) Ambrx Biopharma Inc. (NYSE:...
Via
Benzinga
Topics
Product Recall
Exposures
COVID-19
Legal
Product Safety
The Daily Biotech Pulse: Opiant Spikes On Data, OncoSec Rallies On Merck Collaboration, XBiotech Special Dividend
July 07, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 6) Ambrx Biopharma Inc. (NYSE:...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
July 06, 2021
Gainers Advaxis (NASDAQ:ADXS) shares increased by 43.13% to $0.68 during Tuesday's regular session. The current volume of 106.3 million shares is 1084.49% of Advaxis...
Via
Benzinga
61 Biggest Movers From Yesterday
July 07, 2021
Gainers BSQUARE Corporation (NASDAQ: BSQR) shares climbed 77.1% to close at $7.05 on Tuesday on abnormally-high volume. The company’s stock dropped around 10% on Friday....
Via
Benzinga
Mid-Day Market Update: Gold Rises Over 1%; Provention Bio Shares Plunge
July 06, 2021
Midway through trading Tuesday, the Dow traded down 1.09% to 34,408.75 while the NASDAQ rose 0.01% to 14,641.07. The S&P also fell, dropping 0.60% to 4,326.41. The U.S. has...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
42 Stocks Moving In Tuesday's Mid-Day Session
July 06, 2021
Gainers Orbsat Corp. (NASDAQ: OSAT) shares jumped 74% to $9.47. BSQUARE Corporation (NASDAQ: BSQR) shares jumped 48.2% to $5.90 after dropping around 10% on Friday. Bridgeline...
Via
Benzinga
Mid-Morning Market Update: Markets Mostly Lower; ISM Services PMI Falls In June
July 06, 2021
Following the market opening Tuesday, the Dow traded down 0.62% to 34,569.49 while the NASDAQ rose 0.19% to 14,667.72. The S&P also fell, dropping 0.27% to 4,340.67. The U.S....
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why Odonate Therapeutics, Opthea, ALX Oncology, Advaxis and Provention Bio Are Moving Today
July 06, 2021
Odonate Therapeutics, Inc. (NASDAQ: ODT), Opthea Limited (NASDAQ: OPT), ALX Oncology Holdings Inc. (NASDAQ: ALXO), Provention Bio, Inc. (NASDAQ: PRVB) and Advaxis, Inc. (NASDAQ:...
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
July 06, 2021
Tuesday morning, 51 companies reached new 52-week lows. Noteworthy Highlights: China Life Insurance Co (NYSE:LFC) was the largest company by market cap to set a new...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
July 06, 2021
Gainers Advaxis (NASDAQ:ADXS) stock rose 46.9% to $0.69 during Tuesday's pre-market session. The market value of their outstanding shares is at $100.9 million. Axcella...
Via
Benzinga
Provention Bio's Teplizumab Application Receives CRL For Type-1 Diabetes; Stock Drops
July 06, 2021
The FDA has issued a Complete Response Letter (CRL) to Provention Bio Inc's (NASDAQ: PRVB) teplizumab marketing application seeking approval for the delay...
Via
Benzinga
Exposures
Product Safety
28 Stocks Moving in Tuesday's Pre-Market Session
July 06, 2021
Gainers Odonate Therapeutics, Inc. (NASDAQ: ODT) shares rose 38.3% to $4.80 in pre-market trading following 13G from Ikarian Capital showing a 5.2% stake in the company. BSQUARE...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.